ADORA1 and breast carcinoma: However, ER is also known to use non-classical pathways via Activator protein 1 (AP-1) or via Specificity protein 1 (Sp-1).50 In ER-positive, breast cancer cell lines, ER enhanced ADORA1 mRNA and protein levels.